Tilray and AB InBev Launch Canadian Research Partnership
December 20, 2018
New York - Paul Hastings, a leading global law firm, announced today that the firm represented Tilray, Inc., a global pioneer in cannabis production and distribution on the formation of a research partnership with AB InBev, the world’s leading brewer. The partnership is focused on research for non-alcoholic beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD), and is limited to Canada.
Tilray’s participation in the partnership will be through its Canadian adult-use cannabis subsidiary, High Park Company, and AB InBev will participate via Labatt Breweries of Canada. Each intends to invest up to $50 million in the partnership, for a total of up to $100 million.
At Paul Hastings, our purpose is clear—to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.